Article Text
Abstract
Introduction/Background It is a matter of debate whether there are other factors that may affect the results of colposcopic biopsy independent of cytology and humanpapilloma virus (HPV) genotype results. Therefore, we evaluated the effect of age and reproductive status on clinical outcomes in patients who underwent colposcopy.
Methodology Patients who underwent colposcopic examination at department of Gynecological Oncology, between 2016 and 2020 were evaluated retrospectively. Patients with positive cervical cytology results or patients with unknown HPV type(s) were not considered. Only patients with HPV 16 positivity and normal smear results were evaluated. Patients who had previously undergone colposcopy or a diagnostic excisional procedure were excluded. Statistical analysis was performed using IBM SPSS for Windows, Version 25.0.
Results Of 404 patients, 317 (78.5%) were in the reproductive period and 87 (21.5%) were in the menopausal period. The mean age of reproductive-aged women was 38.4 ± 0.3, and the menopausal women was 54.7 ± 0.5. The incidence of biopsy-confirmed normal cervix, cervical intraepithelial neoplasia (CIN) 1, 2, 3 and cervical cancer were 242/404 (59.9%), 73/404 (18.1%), 31/404 (7.7%), 53/404 (13.1%), and 5/404 (1.2%), respectively (figure 1A). A significant statistical difference was found in the distribution between premenopausal and menopausal patients (p= 0.018). If we classify the biopsy results in 2 groups as CIN 1 and CIN 2+ (CIN 2 and more severe lesion or cancer); CIN 2+ was present in 78/239 (32.6%) of premenopausal patients and 11/76 (14.5%) of menopausal patients (p= 0.017, figure 1B). Cervical cancer in the menopausal period was not observed in our data.
Conclusion The rate of low-grade cervical dysplasia is higher in menopausal patients with HPV 16 positive and normal cervical cytology compared to reproductive-aged patients.
Disclosures The authors have no potetial conflict of interest to report.